Clinical Advances in Nasopharyngeal Carcinoma - Episode 9
Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects
Victoria M. Villaflor, MD, discusses the integration of PD-1 inhibitors into standard treatment practices for patients with nasopharyngeal carcinoma.
Video Player is loading.
Video content above is prompted by the following:
What are the potential benefits of integrating PD-1 inhibitors into standard treatment protocols for NPC?
- What does the future look like for PD-1 Inhibitors in NPC?
Related Content:
